Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Pliant Therapeutics Inc (PLRX)

Pliant Therapeutics Inc (PLRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.4600 -0.1100 (-7.01%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.4600 unch (unch) 19:29 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.4500
Day High
1.5500
Open 1.5400
Previous Close 1.5700 1.5700
Volume 653,400 653,400
Avg Vol 1,112,815 1,112,815
Stochastic %K 86.39% 86.39%
Weighted Alpha -62.08 -62.08
5-Day Change unch (unch) unch (unch)
52-Week Range 1.1001 - 16.5200 1.1001 - 16.5200
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 96,376
  • Shares Outstanding, K 61,386
  • Annual Sales, $ 0 K
  • Annual Income, $ -210,300 K
  • EBIT $ -228 M
  • EBITDA $ -224 M
  • 60-Month Beta 1.46
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.31

Options Overview Details

View History
  • Implied Volatility 245.07% ( -14.90%)
  • Historical Volatility 71.30%
  • IV Percentile 88%
  • IV Rank 45.03%
  • IV High 466.81% on 04/11/25
  • IV Low 63.43% on 09/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 13
  • Volume Avg (30-Day) 66
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 2,264
  • Open Int (30-Day) 3,320

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.72
  • Number of Estimates 4
  • High Estimate -0.38
  • Low Estimate -0.86
  • Prior Year -0.78
  • Growth Rate Est. (year over year) +7.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1001 +32.72%
on 04/09/25
Period Open: 1.4900
1.5900 -8.18%
on 04/21/25
-0.0300 (-2.01%)
since 03/25/25
3-Month
1.1001 +32.72%
on 04/09/25
Period Open: 10.9200
12.8800 -88.66%
on 02/05/25
-9.4600 (-86.63%)
since 01/24/25
52-Week
1.1001 +32.72%
on 04/09/25
Period Open: 11.8800
16.5200 -91.16%
on 05/15/24
-10.4200 (-87.71%)
since 04/25/24

Most Recent Stories

More News
Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference

PLRX : 1.4600 (-7.01%)
Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

PLRX : 1.4600 (-7.01%)
Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement

PLRX : 1.4600 (-7.01%)
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results

PLRX : 1.4600 (-7.01%)
Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

PLRX : 1.4600 (-7.01%)
Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

PLRX : 1.4600 (-7.01%)
Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

PLRX : 1.4600 (-7.01%)
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

PLRX : 1.4600 (-7.01%)
Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical Officer

PLRX : 1.4600 (-7.01%)
Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

PLRX : 1.4600 (-7.01%)

Business Summary

Pliant Therapeutics Inc. is a late-stage biopharmaceutical company which involved in the discovery and development of novel therapeutics for the treatment of fibrotic diseases. The company's lead product candidate includes bexotegrast. Pliant Therapeutics Inc., formerly known as PLANT THERAPEUT, is based...

See More

Key Turning Points

3rd Resistance Point 1.6233
2nd Resistance Point 1.5867
1st Resistance Point 1.5233
Last Price 1.4600
1st Support Level 1.4233
2nd Support Level 1.3867
3rd Support Level 1.3233

See More

52-Week High 16.5200
Fibonacci 61.8% 10.6296
Fibonacci 50% 8.8101
Fibonacci 38.2% 6.9905
Last Price 1.4600
52-Week Low 1.1001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective